Moderna fourth-quarter revenue beats estimates

Investing.com -- Moderna Inc (NASDAQ: MRNA) has reported a steep drop in fourth-quarter revenue to $2.81 billion, but still topped average analyst expectations.

Shares in the U.S. drugmaker were higher in premarket trading on Thursday.

This is a developing story. Please check back later for updates.

You May Also Be Interested In

• Jefferies Financial stock slips 3% as Fixed Income, Asset Management revenues fall
• Vail Resorts (MTN) Tops Q4 EPS by 1c, Offers Guidance
• Gen Digital CEO addresses GoDaddy acquisition rumors